Back
Design Therapeutics Stock Price Chart
The dark truth about AI
Click here to learn more...
Sell
39
DSGN
Design Therapeutics
Last Price:
5.61
Seasonality Move:
-1.97%
7 Day Trial
ALL ACCESS PASS
$
7
Zero Day Options Trade LIVE Tuesday at 2 p.m. ET!
Discover The Zero Day Loophole (BEFORE Tues at 2 p.m. ET!)- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and DSGN is experiencing slight selling pressure.
Design Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 6.34 | Sell |
| 20-day SMA: | 6.02 | Sell |
| 50-day SMA: | 5.72 | Sell |
| 200-day SMA: | 4.53 | Buy |
| 8-day EMA: | 6.21 | Sell |
| 20-day EMA: | 6.12 | Sell |
| 50-day EMA: | 5.81 | Sell |
| 200-day EMA: | 4.89 | Buy |
Design Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.14 | Buy |
| Relative Strength Index (14 RSI): | 44.1 | Sell |
| Chaikin Money Flow: | -33774 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (5.63 - 6.63) | Sell |
| Bollinger Bands (100): | (4.69 - 6.01) | Buy |
Design Therapeutics Technical Analysis
| Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Design Therapeutics Stock
Is Design Therapeutics Stock a Buy?
- Design Therapeutics share price is 5.60 while DSGN 8-day simple moving average is 6.34, which is a Sell signal.
- The stock price of DSGN is 5.60 while Design Therapeutics 20-day SMA is 6.02, which makes it a Sell.
- Design Therapeutics 50-day simple moving average is 5.72 while DSGN share price is 5.60, making it a Sell technically.
- DSGN stock price is 5.60 and Design Therapeutics 200-day simple moving average is 4.53, creating a Buy signal.
DSGN Technical Analysis vs Fundamental Analysis
Sell
39
Design Therapeutics (DSGN)
is a Sell
Is Design Therapeutics a Buy or a Sell?
-
Design Therapeutics stock is rated a Sell
The current Design Therapeutics [DSGN] share price is $5.60. The Score for DSGN is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
Design Therapeutics Stock Info
Market Cap:
317.08M
Price in USD:
5.60
Share Volume:
281.45K
Design Therapeutics 52-Week Range
52-Week High:
7.77
52-Week Low:
2.25
Sell
39
Design Therapeutics (DSGN)
is a Sell
Design Therapeutics Share Price Forecast
-
What is the Design Therapeutics stock price today?
The Design Therapeutics stock price is 5.60 USD today. -
Will DSGN stock go up or go down?
Design Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Design Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Design Therapeutics is overvalued.
Is Design Therapeutics Stock a Buy?
- Design Therapeutics share price is 5.60 while DSGN 8-day exponential moving average is 6.21, which is a Sell signal.
- The stock price of DSGN is 5.60 while Design Therapeutics 20-day EMA is 6.12, which makes it a Sell.
- Design Therapeutics 50-day exponential moving average is 5.81 while DSGN share price is 5.60, making it a Sell technically.
- DSGN stock price is 5.60 and Design Therapeutics 200-day simple moving average is 4.89, creating a Buy signal.
Fundamental Analysis of Design Therapeutics
Is Design Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.40 per share, and a decrease next year of $0.31 per share.
Technical Analysis of Design Therapeutics
Should I short Design Therapeutics stock?
- DSGN Moving Average Covergence Divergence (MACD) indicator is 0.14, suggesting Design Therapeutics is a Buy
- Design Therapeutics Relative Strength Index (RSI) is 44.1, which suggest Design Therapeutics is oversold
- The Bollinger Bands (25) for Design Therapeutics is (5.63 - 6.63), which suggest Design Therapeutics is a Buy
- The Bollinger Bands (100) for Design Therapeutics is (4.69 - 6.01), which suggest Design Therapeutics is a Buy
* Design Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.